News

Understanding Soleno Therapeutics' Current Options Activity

Understanding Soleno Therapeutics' Current Options Activity

An Overview of Soleno Therapeutics’ Options Activity

Recently, there has been a notable trend in the options market for Soleno Therapeutics, indicating a significant interest amongst investors. The trading patterns of this company, particularly in options, reveal a cautious yet strategic approach from market players.

When examining the options trades involving Soleno Therapeutics, specifically the stock denoted by the ticker SLNO, an interesting picture emerges. Out of ten trades identified, about 40% represent bullish outlooks while a substantial 50% are classified as bearish.

Insight into Price Predictions

Delving deeper into the volume and the open interest associated with these options, market movers seem to focus their sights on a price range between $40.0 and $60.0 for Soleno Therapeutics over the past few months. This price target highlights the expectations of significant fluctuations within that spectrum.

Volume and Open Interest Analysis

Assessing the volume and open interest is vital for investors seeking to understand the viability of engaging with any specific stock. Here, it serves as an indicator of the liquidity and interest surrounding the options associated with Soleno Therapeutics.

Recent data showcases a breakdown of trading patterns, reflecting the behaviors of whales, or major players, in the field. This monitoring is essential to comprehend how trades are evolving within the strike price limits of $40.0 to $60.0 across the past month.

Detailing Soleno Therapeutics’ Recent Options Activity

The following summarizes the largest observed options trades for the ticker SLNO in the period, reflecting the different sentiments across trades and types:

Largest Options Trades Uncovered:

  • SLNO: PUT — TRADE | Sentiment: BULLISH | Expiry: 01/16/26 | Strike: $55.00 | Total Price: $2.0M
  • SLNO: CALL — TRADE | Sentiment: BEARISH | Expiry: 01/17/25 | Strike: $60.00 | Total Price: $820.0K
  • SLNO: PUT — TRADE | Sentiment: NEUTRAL | Expiry: 01/17/25 | Strike: $40.00 | Total Price: $800.0K
  • SLNO: CALL — SWEEP | Sentiment: BULLISH | Expiry: 01/17/25 | Strike: $55.00 | Total Price: $83.5K
  • SLNO: PUT — SWEEP | Sentiment: BEARISH | Expiry: 01/17/25 | Strike: $45.00 | Total Price: $73.3K

Examining Soleno Therapeutics

Soleno Therapeutics Inc is at the forefront of developing innovative therapeutics aimed at treating rare diseases. One of its noteworthy products is the Diazoxide Choline Controlled-Release tablet, specifically designed for managing Prader-Willi Syndrome. The formulation of DCCR tablets is centered around diazoxide choline, a unique compound belonging to the benzothiadiazine class of chemicals.

Given the fluctuations noted in the trading history for their options, now is an apt time to turn our focus onto the performance metrics of the company.

Market Performance of Soleno Therapeutics

  • The current trading volume stands at 2,551,056, with the SLNO stock reflecting a rise of 8.21%, currently priced at $51.54.
  • Technical indicators such as the Relative Strength Index (RSI) suggest that SLNO might be nearing an overbought condition.
  • Investors can anticipate upcoming earnings announcements in the near future.

Professional Insights and Analyst Ratings

In recent analyses, two industry experts have weighed in on Soleno Therapeutics, projecting an average price target of $70.5, indicative of a positive sentiment surrounding the stock.

One notable shift comes from an analyst firm lowering its rating to Overweight, with a new price target set at $67. Meanwhile, another firm remains bullish, maintaining a Buy rating with a target price of $74.

Engaging in options trading inherently carries risks but offers opportunities for substantial rewards. Experienced traders often approach these risks methodically, employing ongoing education and strategic adjustments based on market dynamics. Staying updated with real-time options data for Soleno Therapeutics can greatly benefit traders looking to make informed decisions.

Frequently Asked Questions

What is the recent trading activity for Soleno Therapeutics?

Recent options trading indicates a mix of bullish and bearish sentiments, with most trades focused on a price window between $40.0 and $60.0.

What does the SLNO stock price indicate?

The SLNO stock recently rose to $51.54, showing an 8.21% increase, signaling a favorable trading environment.

What are the predictions for Soleno Therapeutics?

Analysts propose an average target price for SLNO around $70.5, suggesting a potential for growth.

What are the risks involved in options trading?

Options trading involves significant risks but can lead to higher profits if managed wisely through continuous learning and strategic planning.

How can I keep updated on Soleno Therapeutics?

Investors can track real-time options data and market news to stay informed about Soleno Therapeutics through various financial platforms.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Huairen Ceramics: Tech Upgrade Powers Global Aspirations

Updated Category News Views 163

Tech Revolution in Porcelain's Traditional Hearth Imagine robots glazing porcelain and kilns all on autopilot—that's the new norm at Huairen City, Shanxi Province, home to China's formidable porcelain industry. Gone are the days when craftsmen relied solely on their keen senses to judge the right glaze and firing time. The latest technology has disrupted tradition here,...

Continue Reading
DIR Launches WineWalrus: A New Era for Wine Lovers

Updated Category News Views 53

The Wine Industry's Digital Splash Ah, the wonderful world of wine—a place where culture, taste, and that sweet bouquet of a well-aged vintage collide. It’s no secret that the wine industry is a cash cow, raking in more than $323 billion annually in the U.S. alone. Digital Information Resources (DIR), a savvy player in tech and media circles, decided this bubbling...

Continue Reading
Databento's $100M Series C: A Game Changer for Market Data

Updated Category News Views 25

Databento Defies Industry Norms Right out of the gate, this Databento story is a head-turner. They just rolled out the big guns with $100 million in fresh Series C financing, and it catapults them to a $1.1 billion valuation. Now, if that doesn't make you sit up and take notice, what will? They've done this while keeping headcount lean, just 39 stalwart employees—talk...

Continue Reading
GAC Opens Flagship Showroom in Cairo: North Africa Push

Updated Category News Views 11

Jumping Into Cairo: GAC's Bold North African Move Ah, the automotive industry, always revvin' up in ways that catch even seasoned traders off guard. This time, GAC Group, the big wheels turning over in China, has planted its flag right in the heart of Cairo with an all-new flagship showroom. We're talking slick, full-throttle action announced on October 27, 2026,...

Continue Reading
Miami Gala Raises $200K for Teen Emotional Health

Updated Category News Views 37

A Night of Giving and Growth in Miami Ever felt like a single evening could change the world? Well, that's exactly what happened on November 7th at the Britto Palace in Miami. The Ismael Cala Foundation pulled off a remarkable feat, raising over $200,000 to boost emotional intelligence among teens through its annual gala, Legacy of Light: A Night of Joyful Giving. The...

Continue Reading
NJ Water Boosts Fire & EMS Grants to $5K in 2027

Updated Category News Views 23

Water Utility Backs First Responders with Bigger Bucks Listen up, folks. The New Jersey American Water company just threw down the gauntlet with some bold moves for its 2027 Volunteer Fire and EMS Grant Program. They've taken the maximum grant amount from $2,500 to $5,000. Yeah, you heard right. Doubling the pot and starting the application cycle earlier means volunteer...

Continue Reading
DIAGENS Smashes AI Benchmarks, Revolutionizes Imaging

Updated Category News Views 52

DIAGENS Shakes Up Medical Imaging with AI Prowess When it comes to revolutionizing how the healthcare sector tackles imaging, DIAGENS (HKEX: 2526) is firing on all cylinders. Their latest marvel, iMed-6.0, is here, packing a punch with its new suite of features that leave others eating dust. Ever seen a company turn the tables like this? Well, strap in because DIAGENS...

Continue Reading
Identity Safety Boost: Veteran Launches AIIS

Updated Category News Views 66

Reckoning with Identity Theft on a New Scale Eric Haller spent decades in the thick of fraud prevention, working at both Experian and TransUnion. But it wasn't until his own identity was swiped clean that the gravity of the issue hit home. Spurred by this personal crisis, he's now spearheading the American Institute for Identity Safety (AIIS), putting a strongfoot forward...

Continue Reading
Laekna: LAE124 Poised for Obesity Week Spotlight

Updated Category News Views 20

LAE124 Could Shake Up Obesity Treatment Norms Just roll the dice on innovation sometimes, because that's when you get a spark. Laekna, a name you’ve heard in biotech circles, is gearing up to showcase LAE124 at Obesity Week 2026. This ain't just another weight-loss compound tossed into the market. We're talking about a new small-molecule dual Amylin/Calcitonin receptor...

Continue Reading
ATI's Aggressive 2029 Targets: A Bold Vision Unveiled

Updated Category News Views 23

ATI's Strategy: No Rest for the Ambitious So, ATI (NYSE:ATI) isn't just sitting on its hands, staring at numbers from the last fiscal year. They're out here, shaking up the market with some serious plans. At their Investor Day shindig, they dished out a strategy as bold as breakfast coffee—targeting double-digit growth and expanded margins by 2029. Call it audacious or...

Continue Reading

Top 5 Most Recently Viewed Articles

Rubis Challenges French Competition Authority's Penalties

Updated Category News Views 209

Rubis Responds to Competition Authority's Decision Rubis has taken note of a significant ruling from the French Competition Authority, which has announced sanctions against various players involved in the fuel supply chain in Corsica. This ruling, which has drawn considerable attention, comes as a response to alleged anti-competitive behaviors reported between 2016 and...

Continue Reading
Germany Considers New Law to Safeguard Domestic Bank Interests

Updated Category News Views 181

Germany Explores Legislation to Protect Domestic Banking Sector Germany is on the brink of introducing new regulations aimed at shielding its domestic banking sector from foreign acquisitions. This decision emerges amidst growing tensions related to foreign investment in local institutions, particularly in light of recent developments involving Italy's UniCredit and...

Continue Reading
Understanding the Surge in Global Bond Yields and Its Impact

Updated Category News Views 408

The Surge in Global Bond Yields: An Overview In recent weeks, a significant increase in government-bond yields across developed nations has become a topic of discussion, causing ripples in the stock market and intensifying challenges for heavily indebted nations. Impact on Central Banks and Borrowing Costs The current bond market turmoil might pose challenges for central...

Continue Reading
Biodexa Pharmaceuticals Secures Nasdaq Listing Compliance Extension

Updated Category News Views 89

Biodexa Pharmaceuticals Achieves Nasdaq Listing Milestone Biodexa Pharmaceuticals PLC (NASDAQ: BDRX), an innovative clinical stage biopharmaceutical company, recently celebrated a significant milestone in its journey as it announced a successful appeal to the Nasdaq Hearings Panel. This achievement allows the company additional time to demonstrate compliance with Nasdaq's...

Continue Reading
Rathbones Group Discovers New Opportunities with Idox Plc

Updated Category News Views 111

Understanding the Public Opening Position Disclosure In the realm of finance and corporate governance, transparency is key. The Public Opening Position Disclosure serves a critical function in ensuring that all significant shareholding interests are made known to the relevant authorities and the public. It enhances trust and accountability among stakeholders and is...

Continue Reading